Catmose Animal Health Ltd 15064487 false 2023-08-11 2024-08-31 2024-08-31 The principal activity of the company is the provision of veterinary services. The company began trading post year end on 2 September 2024. Digita Accounts Production Advanced 6.30.9574.0 true true 15064487 2023-08-11 2024-08-31 15064487 2024-08-31 15064487 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-08-31 15064487 bus:OrdinaryShareClass2 bus:CumulativeShares 2024-08-31 15064487 bus:OrdinaryShareClass3 bus:CumulativeShares 2024-08-31 15064487 core:ShareCapital 2024-08-31 15064487 core:HirePurchaseContracts core:CurrentFinancialInstruments 2024-08-31 15064487 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2024-08-31 15064487 core:CurrentFinancialInstruments 2024-08-31 15064487 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 15064487 core:Non-currentFinancialInstruments 2024-08-31 15064487 core:Non-currentFinancialInstruments core:AfterOneYear 2024-08-31 15064487 bus:SmallEntities 2023-08-11 2024-08-31 15064487 bus:AuditExemptWithAccountantsReport 2023-08-11 2024-08-31 15064487 bus:FilletedAccounts 2023-08-11 2024-08-31 15064487 bus:SmallCompaniesRegimeForAccounts 2023-08-11 2024-08-31 15064487 bus:RegisteredOffice 2023-08-11 2024-08-31 15064487 bus:Director1 2023-08-11 2024-08-31 15064487 bus:Director2 2023-08-11 2024-08-31 15064487 bus:OrdinaryShareClass1 bus:CumulativeShares 2023-08-11 2024-08-31 15064487 bus:OrdinaryShareClass2 bus:CumulativeShares 2023-08-11 2024-08-31 15064487 bus:OrdinaryShareClass3 bus:CumulativeShares 2023-08-11 2024-08-31 15064487 bus:PrivateLimitedCompanyLtd 2023-08-11 2024-08-31 15064487 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-08-11 2024-08-31 15064487 countries:EnglandWales 2023-08-11 2024-08-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 15064487

Prepared for the registrar

Catmose Animal Health Ltd

Annual Report and Unaudited Financial Statements

for the Period from 11 August 2023 to 31 August 2024

 

Catmose Animal Health Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 6

 

Catmose Animal Health Ltd

Company Information

Directors

V Ortiz Valderrey

A Ortiz

Registered office

Goodwood House
Hackamore Way
Barleythorpe
Oakham
LE15 7FS

Accountants

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

Catmose Animal Health Ltd

(Registration number: 15064487)
Balance Sheet as at 31 August 2024

Note

2024
£

Current assets

 

Debtors

4

164,716

Cash at bank and in hand

 

209,104

 

373,820

Creditors: Amounts falling due within one year

5

(116,661)

Total assets less current liabilities

 

257,159

Creditors: Amounts falling due after more than one year

5

(256,959)

Net assets

 

200

Capital and reserves

 

Called up share capital

7

200

Shareholders' funds

 

200

For the financial period ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 28 April 2025 and signed on its behalf by:
 


V Ortiz Valderrey
Director


A Ortiz
Director

 

Catmose Animal Health Ltd

Notes to the Unaudited Financial Statements for the Period from 11 August 2023 to 31 August 2024

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Goodwood House
Hackamore Way
Barleythorpe
Oakham
LE15 7FS

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Catmose Animal Health Ltd

Notes to the Unaudited Financial Statements for the Period from 11 August 2023 to 31 August 2024

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Catmose Animal Health Ltd

Notes to the Unaudited Financial Statements for the Period from 11 August 2023 to 31 August 2024

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.


Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.


Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 2.

 

4

Debtors

2024
£

Prepayments

142,998

Other debtors

21,718

164,716

 

5

Creditors

Note

2024
£

Due within one year

 

Loans and borrowings

6

79,574

Trade creditors

 

37,087

 

116,661

Note

2024
£

Due after one year

 

Loans and borrowings

6

256,959

 

Catmose Animal Health Ltd

Notes to the Unaudited Financial Statements for the Period from 11 August 2023 to 31 August 2024

 

6

Loans and borrowings

Current loans and borrowings

2024
£

Hire purchase contracts

6,441

Other borrowings

73,133

79,574

Non-current loans and borrowings

2024
£

Bank borrowings

225,000

Hire purchase contracts

31,959

256,959

 

7

Share capital

Allotted, called up and fully paid shares

 

31 August 2024

 

No.

£

Ordinary shares of £1 each

50

50

Ordinary B shares of £1 each

50

50

Ordinary C shares of £1 each

100

100

 

200

200

During the period 50 Ordinary shares having an aggregate nominal value of £1 were allotted for an aggregate consideration of £50.

During the period 50 Ordinary B shares having an aggregate nominal value of £1 were allotted for an aggregate consideration of £50.

During the period 100 Ordinary C shares having an aggregate nominal value of £1 were allotted for an aggregate consideration of £100.

 

8

Related party transactions

Summary of transactions with key management

Key management personnel are considered to be the directors of the company.

As at 31 August 2024, the company owed the directors £73,333. This amount is included within other borrowings. There are no fixed repayment terms and no interest is charged.